Insulin, which drives growth in the prenatal period, has been cited as a possible mechanism behind the “growth without GH” syndrome, as obesity-induced hyperinsulinemia may stimulate hepatic production of IGF-I. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.